Division 1.3.1 The appropriate classification developed in accordance with the criteria in Regulation (EC) No 1272/2008 shall be presented and justified. Where applicable, Specific Concentration limits resulting from the application of Article 10 of Regulation (EC) No 1272/2008 ... shall be presented and, if they are not included in the GB mandatory classification and labelling list , justified.X1F1F2F3
United Kingdom
F4The assessment should always include a statement as to whether the substance or, when applicable, nanoforms thereof fulfils or does not fulfil the criteria given in Regulation (EC) No 1272/2008 for classification in the hazard class carcinogenicity category 1A or 1B, in the hazard class germ cell mutagenicity category 1A or 1B or in the hazard class reproductive toxicity category 1A or 1B.
Annotations
Textual amendments
- F1
- F2
-
Words in Annex 1 point 1.3.1 omitted (31.12.2020) by virtue of The REACH etc. (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/758), reg. 1(1), Sch. 3 para. 1(4); 2020 c. 1, Sch. 5 para. 1(1)
- F3
-
Words in Annex 1 point 1.3.1 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 5(a) (as amended by S.I. 2020/1567, reg. 1(2), Sch. 2 para. 2(d)); 2020 c. 1, Sch. 5 para. 1(1)
- F4